Fears of a hepatitis C "serial infector" are rising after testing for more than 3,000 people who...
Fears of a hepatitis C "serial infector" are rising after testing for more than 3,000 people who may have been infected was cancelled by officials after the system became overwhelmed. A former lab technician at a New Hampshire hospital was indicted last week for allegedly infecting 31 people with the virus. Biotech shares that specialize in the field are active: GILD +0.5%, VRTX +1.3%, IDIX +1%.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Benzinga.com (Fri, 12:50PM)
at Benzinga.com (Wed, 3:29PM)
at Nasdaq.com (Feb 20, 2015)
at Benzinga.com (Feb 20, 2015)
at Investor's Business Daily (Feb 4, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs